CGTX
Price:
$0.5698
Market Cap:
$22.87M
Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical trial for the treatment of mild-to-moderate Alzheimer's disease, as well as has completed Phase I clinical trial to treat early-stage Alzheimer's disease; in Phase II clinical trial for the treatment of dementia with Lewy bodies (DLB); and in preclinical trial to treat dry age-related macular degeneration (AMD). The company is also developing CT2168 for...[Read more]
Industry
Biotechnology
IPO Date
2021-10-08
Stock Exchange
NASDAQ
Ticker
CGTX
According to Cognition Therapeutics, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.61. This represents a change of -67.44% compared to the average of -1.87 of the last 4 quarters.
The mean historical PE Ratio of Cognition Therapeutics, Inc. over the last ten years is -0.70. The current -0.61 PE Ratio has changed 8.64% with respect to the historical average. Over the past ten years (40 quarters), CGTX's PE Ratio was at its highest in in the March 2021 quarter at 305.96. The PE Ratio was at its lowest in in the June 2021 quarter at -44.89.
Average
-0.70
Median
-13.66
Minimum
-40.29
Maximum
80.43
Discovering the peaks and valleys of Cognition Therapeutics, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = 80.43
Minimum Annual Increase = -688.76%
Minimum Annual PE Ratio = -40.29
Year | PE Ratio | Change |
---|---|---|
2023 | -2.15 | -102.68% |
2022 | 80.43 | -688.76% |
2021 | -13.66 | -50.89% |
2020 | -27.81 | -30.97% |
The current PE Ratio of Cognition Therapeutics, Inc. (CGTX) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
21.54
5-year avg
-0.70
10-year avg
-0.70
Cognition Therapeutics, Inc.’s PE Ratio is greater than Reviva Pharmaceuticals Holdings, Inc. (-1.10), greater than Eyenovia, Inc. (-0.70), less than TransCode Therapeutics, Inc. (-0.10), greater than Kodiak Sciences Inc. (-0.61), less than TFF Pharmaceuticals, Inc. (-0.34), greater than TScan Therapeutics, Inc. (-6.03), greater than Cue Biopharma, Inc. (-0.63), less than Dermata Therapeutics, Inc. (-0.11), greater than Gain Therapeutics, Inc. (-0.93), greater than aTyr Pharma, Inc. (-2.33), less than IN8bio, Inc. (-0.43), greater than Lantern Pharma Inc. (-2.07), less than Cullinan Oncology, Inc. (0), greater than Bolt Biotherapeutics, Inc. (-6.96), less than Day One Biopharmaceuticals, Inc. (-0.37), greater than Lyra Therapeutics, Inc. (-7.39), less than Autolus Therapeutics plc (-0.18), greater than null (-4.55),
Company | PE Ratio | Market cap |
---|---|---|
-1.10 | $42.03M | |
-0.70 | $37.99M | |
-0.10 | $4.56M | |
-0.61 | $121.54M | |
-0.34 | $6.20M | |
-6.03 | $294.00M | |
-0.63 | $28.70M | |
-0.11 | $2.08M | |
-0.93 | $26.81M | |
-2.33 | $131.12M | |
-0.43 | $14.22M | |
-2.07 | $36.82M | |
0 | $1.04B | |
-6.96 | $24.78M | |
-0.37 | $1.25B | |
-7.39 | $17.85M | |
-0.18 | $1.07B | |
-4.55 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cognition Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cognition Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cognition Therapeutics, Inc.'s PE Ratio?
How is the PE Ratio calculated for Cognition Therapeutics, Inc. (CGTX)?
What is the highest PE Ratio for Cognition Therapeutics, Inc. (CGTX)?
What is the 3-year average PE Ratio for Cognition Therapeutics, Inc. (CGTX)?
What is the 5-year average PE Ratio for Cognition Therapeutics, Inc. (CGTX)?
How does the current PE Ratio for Cognition Therapeutics, Inc. (CGTX) compare to its historical average?